BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3809233)

  • 1. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
    Smolen TN; Smolen A; Collins AC
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
    Van de Kamp JL; Collins AC
    Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
    Marks MJ; Collins AC
    Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in affinity states during down-regulation of muscarinic receptors in tracheal smooth muscle of organophosphate-treated swine.
    Yang CM; Mohan PM; Dwyer TM; Farley JM
    J Auton Pharmacol; 1988 Jun; 8(2):79-91. PubMed ID: 3170629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic changes in the density of muscarinic and beta-adrenergic receptors in cardiac atria of rats treated with diisopropylfluorophosphate.
    Myslivecek J; Trojan S; Tucek S
    Life Sci; 1996 May; 58(26):2423-30. PubMed ID: 8691987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
    Costa LG; Schwab BW; Murphy SD
    Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
    Costa LG; Murphy SD
    Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation.
    Levy A; Zohar J; Belmaker RH
    Neuropharmacology; 1982 Nov; 21(11):1199-201. PubMed ID: 7177345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of diisopropylfluorophosphate, paraoxon and dichlophos on [3H] quinuclidinyl benzylate binding to the rat striatum synaptic membranes].
    Golovko AI; Sofronov GA; Nikolaeva TV; Kliuntina TV
    Biull Eksp Biol Med; 1992 Sep; 114(9):290-1. PubMed ID: 1477363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of tolerance development after chronic oxotremorine treatment.
    Marks MJ; Artman LD; Collins AC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 1. Agonist changes.
    Murali Mohan P; Huang Saunders HM; Yang CM; Dwyer TM; Farley JM
    J Auton Pharmacol; 1988 Jun; 8(2):93-106. PubMed ID: 2902099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mu-opioid receptors in development of tolerance to diisopropylfluorophosphate (DFP).
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Toxicol Sci; 2005 Feb; 30(1):43-59. PubMed ID: 15800401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.